Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670913
Status:
UNKNOWN
Last Update Posted:
2021-06-29
First Post:
2020-11-26
Brief Title:
Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy
Sponsor:
Organization:
Peking Union Medical College